Jonathan E. Levitt, Esq., co-founded the boutique Healthcare law firm of Frier Levitt, LLC in 2000. The Firm enjoys a national foothold in Life Sciences and Healthcare. Beginning with a 2003 nationwide class action of independent pharmacies, Jonathan began his journey to both understand all aspects of the drug space and develop skills relevant to multiple stakeholders. Frier Levitt has grown to more than 35 Healthcare-focused attorneys, including clinician attorneys, with offices in New York City and Pine Book, New Jersey.
Jonathan has dedicated his practice to representing pharmacies, physician-dispensers, national provider associations, manufacturers, wholesalers, and plan sponsors. He has an established track record of challenging abusive practices of Pharmacy Benefit Managers (PBMs) and speaks at Life Sciences conferences across the country in an effort to share his firm’s specialized knowledge. Jonathan is the author of the LinkedIn Group “Hot Topics in Pharmacy Law” and has been published in internationally-circulated publications. He commits himself to pro bono and public service assignments.
For the last 13 years, Jonathan’s peers have elected him as a Super Lawyer. Jonathan is Certified by the Supreme Court of New Jersey as a Civil Trial Attorney. Jonathan has competed in triathlons, including the 2012 New York Ironman U.S. Championships, as well as Brazilian Jiu Jitsu.
Legal: New York Law School, Juris Doctor, cum laude
Articles Editor – New York Law School Law Review
Undergraduate: Rutgers College, Rutgers University
- State of New Jersey
- State of New York
- Commonwealth of Pennsylvania
- State of Missouri
- State of Arizona
- District of Columbia Court of Appeals
- United States District Court for the District of Columbia
- U.S. District Court, New Jersey
- U.S. District Court for the Southern and Eastern Districts of New York
- United States Court of Appeals for the Third Circuit
- United States District Court for the Eastern District of Michigan
- American Bar Association
- New Jersey State Bar Association
- New York State Bar Association
- American Trial Lawyers Association
- Computer Law Association
- American Trial Lawyers Association – Construction Site Accident Litigation Group
- Nail Gun Injury Group
- National Association of Specialty Pharmacy
“Plan Sponsor Alert: Truths About PBM and Manufacturer Rebates,” BenefitsPRO, May 20, 2020.
“Owning an In-Network Pharmacy and a Second Out-of-Network Pharmacy that Performs Compounding,” International Journal of Pharmaceutical Compounding, March 2010.
“Tips to Avoid Clashes Over Real Estate Commissions,” New Jersey Real Estate Journal, July 30, 2001.
In June 2017, Jonathan presented “Preventing Unfair PBM Reimbursement and Strategies to Level The Playing Field” at the New Jersey Society of Oncology Managers (NJSOM) Annual Conference.
In March 2017, Jonathan presented “DIR Fees and Implications in HI Specialty Pharmacy” at the 14th Annual MHA Business Summit.
In March 2017, Jonathan presented “Challenging Abusive PBM Policies: A Case Study Into PBM Treatment of ‘Physician Dispensing’ and DIR Fees” for the National Community Oncology Dispensing Association (NCODA) 2017 Forum.
In February 2017, Jonathan presented “Legal Considerations for Chain Pharmacies in the Changing Reimbursement Landscape” at the National Association of Chain Drug Stores (NACDS) Regional Chain Conference.
In January 2017, Jonathan presented “Legal and Business Considerations for Human Resources When Addressing Pharmacy Benefits” at the Marcus Evans Employer Benefits Conference.
In 2017, Jonathan presented a webinar regarding “DIR Fees: What Are They and What Can Specialty Pharmacies Do About Them” in conjunction with National Association of Specialty Pharmacy (NASP).
In October 2016, Jonathan presented “Is PBM Power Limitless? A Look at Recent PBM conduct: CVS Physician Dispensing Guidance, ESI on Oral Oncolytic Exclusivity, and DIR Fees” at the 2016 NCODA Annual Symposium.
In 2016, Jonathan presented webinars in partnership with Mediware, including, “Medicare Part D: DIR Fees and ‘Preferred Cost Sharing Networks,” “Utilizing the Federal ‘Any Willing Provider’ Law to Access Medicare Part D Networks,” and “Governmental Investigations of Pharmacies and PBM Audits – The Rise in Medicaid Investigations and Changing PBM Audits.”
In June 2016, Jonathan presented a webinar regarding “Preparing Your Specialty Pharmacy for a Private Equity Acquisition” in conjunction with CohnReznick and the CSI Specialty Group.
Annually, Jonathan gives lectures regarding various legal, regulatory and contractual issues for organizations like IACP and ACA, speaking events including: IACP Educational Conference (2013, 2014, 2015), Compounders on Capitol Hill (2014, 2015), and the ACA – Compounding, What’s Happening Conference (2014, 2015)
Jonathan has also lectured at multiple events for Freedom Pharmaceuticals, including CPSI classes (August, September, and October 2013; November 2014, March 2015) and the Freedom Annual Seminar (2014, 2015).
In 2015, Jonathan gave a webinar for ACA regarding 503B Outsourcing Facilities and one for ACVP regarding Veterinary Compounding. He also spoke at the Mediware Elevate 2015 Conference regarding Specialty Pharmacies.
In 2013, Jonathan gave several lectures regarding various legal, regulatory, and contractual issues relating to pharmacies at Freedom Pharmaceuticals, Tulsa, OK.
In November 2011, Jonathan spoke at the NASPA Fall Symposium regarding changes in major PBM auditing practices and trends and PBM Manual revisions.
In April 2011, Jonathan spoke at the Independent Pharmacy Cooperative Conference regarding pharmacy audits.
In October 2010, Jonathan spoke at the National Community Pharmacists Association National Convention. The topic was “Navigating the Legal Waters of the Pharmacy Marketplace.”
In January 2010, Jonathan lectured to a group of attorneys at the Federal Trade Commission on the topic of pharmacy benefits management.
In October 2009, Jonathan was invited to speak at the National Community Pharmacists Association National Convention about various topics impacting community pharmacists.
On January 12, 2009, Jonathan E. Levitt, Esq. appeared on Fox Business News with David Asman’s America’s Nightly Scoreboard to discuss the Bernard Madoff Investment Securities, LLC scandal.
Jonathan has been selected for inclusion on the New Jersey Super Lawyers list from 2011 – 2020.
Jonathan was selected for inclusion on the New Jersey Rising Stars list from 2006-2010.
In August 2008, Jonathan was certified as a Member of the Million Dollar Advocates Forum. Membership is limited to attorneys who have won million and multi-million dollar verdicts, awards and settlements.
In 2007, Jonathan was appointed by the Supreme Court of New Jersey to District VB (Essex County – Suburban Essex) Ethics Committee (four year term beginning September 1, 2007).
In 2005, Jonathan was appointed as Presiding Commissioner on several Newark condemnation matters.
In April 2004, he received a Special Merit Award from the Essex County Bar Association.
In 2003, The Presiding Judge in Essex County appointed Jonathan as the Trustee to preside over the Law Practice of a Deceased Attorney who was a Solo Practitioner.
In 2003, he was appointed as a Co-Commissioner in an Newark Condemnation matter.
*No aspect of this advertisement has been approved by the Supreme Court of New Jersey or the American Bar Association. A description of the standard or methodology on which the accolades are based can be found at: